Story thread · 5 reports / 4 sources
HUTCHMED Lands GSK Deal Worth Up to $1.3B for KRAS-EGFR Cancer Therapy
finance.yahoo.com · 11d
How the coverage leans
Across 4 sources · syndicated copies counted once
First report: Panmure and Cavendish reiterate buy on Hutchmed after GSK deal — finance.yahoo.com, 11d
The coverage
- GSK wagers up to $1.3B on a different kind of cancer drug
biopharmadive.com · 11d
- GSK pays Hutchmed $110M upfront in deal worth up to $1.3B
ijr.com · 11d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.